Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Low molecular weight heparins].

C Doutremepuich, M C Lalanne, M Guyot

    Annales Pharmaceutiques Francaises
    |January 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Studies of the resonance structure in <math> </math> decays.

    The European physical journal. C, Particles and fields·2019
    Same author

    Occurrence of Borrelia and Borreliella species in Ixodes ricinus collected from roe deer in northwestern Spain.

    Medical and veterinary entomology·2019
    Same author

    Observation of a New Ξ_{b}^{-} Resonance.

    Physical review letters·2018
    Same author

    Amplitude Analysis of the Decay B[over ¯]^{0}→K_{S}^{0}π^{+}π^{-} and First Observation of the CP Asymmetry in B[over ¯]^{0}→K^{*}(892)^{-}π^{+}.

    Physical review letters·2018
    Same author

    Lesser housefly (Fannia canicularis) as possible mechanical vector for Aleutian mink disease virus.

    Veterinary microbiology·2018
    Same author

    Evidence for the Rare Decay Σ^{+}→pμ^{+}μ^{-}.

    Physical review letters·2018

    Low molecular weight heparins (LMWHs) offer improved prophylactic treatment for thromboembolic diseases with fewer risks. Establishing a reliable biological assay to correlate with LMWH antithrombotic activity remains a key challenge.

    Area of Science:

    • Pharmacology
    • Biochemistry
    • Hematology

    Context:

    • The introduction of low molecular weight heparins (LMWHs) in the 1980s revolutionized thromboembolic disease prophylaxis.
    • LMWHs offer significant advantages over traditional heparin, including enhanced bioavailability and a reduced risk of bleeding.

    Purpose:

    • To review the established benefits and mechanisms of LMWHs in managing thromboembolic disorders.
    • To highlight the ongoing need for a precise biological assay to quantify LMWH antithrombotic efficacy.

    Summary:

    • LMWHs, derived from heparin, exhibit comparable antithrombotic activity with improved pharmacokinetic profiles and safety.
    • Their mechanism involves multiple interactions with coagulation factors, fibrinolysis, and cellular components, though not fully elucidated.

    Related Experiment Videos

  • While protamine can neutralize LMWHs, a simple, specific assay correlating with antithrombotic action is still needed.

    • Impact:

    • LMWHs have become a cornerstone in the prophylactic and therapeutic management of thromboembolic conditions.
    • Further research into biological assays will refine LMWH treatment and monitoring, optimizing patient outcomes.